Clinical Trial Update: Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of cryosurgery and NK cell immunotherapy for recurrent pharyngeal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pharyngeal Cancer

Drugs mentioned

• Cryosurgery

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Recurrent Pharyngeal Cancer | Phase 1, Phase 2 | Status: COMPLETED